Back to Search
Start Over
DOES TIMING OF CYP2C19 TESTING AFFECT MAJOR ADVERSE CARDIOVASCULAR EVENT AND BLEEDING RISK IN PATIENTS INITIATED ON DUAL ANTI-PLATELET THERAPY? REAL-WORLD EXPERIENCE FROM A POPULATION GENOMIC SCREENING PROGRAM
- Source :
- Journal of the American College of Cardiology. 81:1219
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Cardiology and Cardiovascular Medicine
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 81
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........3ad4a76032291fafe76d5e882afee0ce